News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Bruce Levine Speaks on the Future of CAR-T Therapies
Levine explained that there are currently six approved CAR-T therapies and he estimates that between 25,000 and 30,000 patients have been treated with those therapies globally.
Penn I-Corps Launches Spring 2023 cohort
The cohort started at the end of February and is underway. Teams are currently engaged in reaching out and conducting Customer discovery interviews.
PCI Promotes Innovation and Startups at the South by Southwest (SXSW) annual Interactive Conference
It was a great opportunity to share the innovation initiatives coming out of Penn and Philadelphia with a global audience.
PCI Featured as the Philadelphia Business Journal Cover Story
This in-depth interview with Swartley provides a comprehensive history about technology transfer at Penn as well as the establishment and current success of PCI.
Ligand-tethered Lipid Nanoparticles for Targeted RNA Delivery to Treat Liver Fibrosis
the Mitchell Lab has developed a new class of anisimide-functionalized lipids that enables targeted delivery of lipid nanoparticles (LNPs) to activated fibroblasts in the liver.
Penn Ranks First in Licensing Income
Penn officially ranked number one in terms of licensing income in the latest Association of University Technology Managers (AUTM) annual survey, which included 153 reporting institutions.
PCI Tech Publisher Site Now Has Subscription Feature
The PCI Technology Publisher website recently added a new subscription feature so that you can receive email updates about new technologies from particular inventors, categories, and departments.
Pennovation Accelerator Alumni Develops New Model of 3D Chocolate Printing Press
Ellie Weinstein, Pennovation Accelerator alumni, developed the Cocoa Press to 3D print chocolate.
PCI Activities Highlighted by the CEO Council for Growth
The CEO Council for Growth recently highlighted PCI's annual review and JP Morgan Conference event in its newsletter.
Fake
This technology is an intracerebral drug delivery system that consists of three flexible, retractable microcannulas housed within a single central catheter.